Cargando…
Umbilical cord as a long-term source of activatable mesenchymal stromal cells for immunomodulation
BACKGROUND: Mesenchymal stromal cells (MSCs) are used in over 800 clinical trials mainly due to their immune inhibitory activity. Umbilical cord (UC), the second leading source of clinically used MSCs, is usually cut in small tissue pieces. Subsequent cultivation leads to a continuous outgrowth of M...
Autores principales: | Selich, Anton, Zimmermann, Katharina, Tenspolde, Michel, Dittrich-Breiholz, Oliver, von Kaisenberg, Constantin, Schambach, Axel, Rothe, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755709/ https://www.ncbi.nlm.nih.gov/pubmed/31547865 http://dx.doi.org/10.1186/s13287-019-1376-9 |
Ejemplares similares
-
Cytokine Selection of MSC Clones with Different Functionality
por: Selich, Anton, et al.
Publicado: (2019) -
Inflammation-inducible promoters to overexpress immune inhibitory factors by MSCs
por: Selich, Anton, et al.
Publicado: (2023) -
What Makes Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells Superior Immunomodulators When Compared to Bone Marrow Derived Mesenchymal Stromal Cells?
por: Bárcia, R. N., et al.
Publicado: (2015) -
Human Teratoma-Derived Hematopoiesis Is a Highly Polyclonal Process Supported by Human Umbilical Vein Endothelial Cells
por: Philipp, Friederike, et al.
Publicado: (2018) -
Extracellular Vesicle Depletion Protocols of Foetal Bovine Serum Influence Umbilical Cord Mesenchymal Stromal Cell Phenotype, Immunomodulation, and Particle Release
por: Davies, Rebecca, et al.
Publicado: (2023)